M

Myant

Regulatory Affairs Manager

Full-Time
No salary listed
Mid
Bachelor's
Mississauga, ON, Canada
In Person
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • A bachelor's degree in Biomedical Engineering, Engineering, Software, Life Sciences, Applied Sciences, or a related discipline, or equivalent relevant experience.
  • Several years of progressive Regulatory Affairs experience within the medical device industry.
  • Demonstrated experience with medical device regulatory requirements in Canada, the United States and/or Europe, with strong knowledge of at least two of these jurisdictions.
  • Hands-on experience preparing or supporting medical device regulatory submissions.
  • Demonstrated experience with Software as a Medical Device (SaMD), digital health, connected medical devices, or medical device software.
  • Experience supporting New Product Introduction (NPI) and regulatory activities throughout the product development lifecycle.
  • Experience working within an ISO 13485 and/or MDSAP Quality Management System.
  • A strong understanding of regulatory requirements, standards, and guidance applicable to medical devices and software.
  • Experience working with an electronic Quality Management System (eQMS) and controlled regulatory documentation.
  • Experience supporting internal or external ISO 13485, MDSAP, EU MDR, or regulatory authority audits.
  • Strong project management, organizational, documentation, and communication skills.
  • Ability to work effectively with technical and non-technical stakeholders across a multidisciplinary organization.
  • Ability to manage multiple regulatory projects and priorities in a fast-paced commercialization environment.
Responsibilities
  • Develop and execute regulatory strategies for new medical devices, software products, and modifications to existing products.
  • Lead or support regulatory submissions and approvals across Health Canada, FDA, and European regulatory frameworks, including applicable medical device and SaMD submissions.
  • Prepare and maintain regulatory submission documentation, including technical documentation, regulatory dossiers, submission correspondence, and supporting evidence.
  • Support Health Canada Medical Device Licence (MDL) applications and amendments, as applicable.
  • Support preparation of FDA 510(k), De Novo, and other applicable submissions, including interaction with regulatory authorities where required.
  • Support European regulatory activities under the EU MDR, including CE-marking activities, technical documentation, and conformity assessment.
  • Develop regulatory strategies for software and SaMD, including regulatory classification, intended use, software lifecycle considerations, changes, and updates.
  • Provide regulatory input throughout NPI and product development, ensuring regulatory requirements are incorporated early in the design and development process.
  • Assess regulatory impact of product changes, software releases, design changes, manufacturing changes, and other modifications through established change-control processes.
  • Monitor changes to applicable regulations, standards, and regulatory guidance and assess their impact on products and processes.
  • Work closely with Quality Assurance to ensure regulatory activities are appropriately integrated within the ISO 13485/MDSAP Quality Management System.
  • Collaborate with Product, Engineering, Software, Clinical, Quality, Manufacturing, and Commercial teams to ensure products meet applicable regulatory, quality, and safety requirements.
  • Support regulatory aspects of clinical and performance activities, including determining applicable regulatory requirements and documentation.
  • Maintain regulatory documentation, records, and submissions within the electronic QMS (eQMS) to ensure traceability, accessibility, and inspection readiness.
  • Support regulatory responses to Health Canada, FDA, Notified Bodies, and other regulatory authorities.
  • Support post-market regulatory activities, including regulatory reporting, product changes, vigilance, and other applicable regulatory requirements.
  • Participate in internal and external audits and support regulatory and quality inspection readiness.
  • Participate as an Internal Auditor within the Quality Management System.
  • Manage assigned regulatory projects, timelines, and deliverables and communicate regulatory risks and requirements to stakeholders.
  • Contribute to continuous improvement of regulatory processes, procedures, and systems.
Desired Qualifications
  • Experience with regulatory requirements for wearable, connected, and/or patient-worn medical devices.
  • Experience with FDA 510(k), De Novo, or other FDA medical device pathways.
  • Experience with Health Canada MDL/MDEL requirements.
  • Experience with EU MDR technical documentation and CE marking.
  • Experience with regulatory requirements related to clinical evaluation, software lifecycle, cybersecurity, risk management, and usability/human factors.
  • Experience with IEC 62304, ISO 14971, IEC 62366, and/or other medical device software and risk-management standards.
  • Experience with regulatory strategy for connected/IoT medical devices.
  • Internal Auditor, RAC, RAPS, ISO 13485 Auditor, or equivalent certification.
  • Experience working with regulators, Notified Bodies, Certification Bodies, or external regulatory consultants.

About the company

Company Size

51-200

Company Stage

N/A

Total Funding

$1.5M

Headquarters

Toronto, Canada

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • March 2026 NGen named Myant a lead partner for AI manufacturing.
  • Myant launched Care360 in March 2025 and expanded remote cardiac assessments in 2026.
  • Acquiring FIGUR8 in April 2026 broadened Myant into musculoskeletal analytics and recovery.

What critics are saying

  • Care360 revenue depends on reimbursement; Ontario coverage alone cannot fund national expansion.
  • FIGUR8, Bitnobi, mmHg, and AiQ integrations will distract engineering through 2026.
  • If clinical adoption stalls, Myant becomes a low-margin materials supplier with no software moat.

What makes Myant unique

  • Myant owns the textile-computing stack: fibers, sensors, garment design, and clinical software.
  • January 2026 AiQ integration gave Myant Taiwan manufacturing and Asian market access.
  • Care360 pairs Health Canada-licensed remote cardiac monitoring with direct-to-patient fulfillment.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Company News

EIN Presswire
Jan 20th, 2026
Myant acquires majority stake in AiQ Smart Clothing to scale medical-grade e-textiles

Myant, a Toronto-based textile computing company, has acquired a controlling majority stake in a joint venture with TexRay Industrial to integrate AiQ Smart Clothing into its ecosystem. The move combines Canadian innovation in textile computing with Taiwan's manufacturing capabilities to create a standardised platform for medical-grade e-textile components. AiQ customers will gain access to Myant's digital textile platform and manufacturing capabilities. The merged portfolio includes advanced sensing technology from Nanoleq alongside AiQ's 15 years of experience in smart apparel, offering functionalized yarns, conductive tapes and textile-to-electronics interfaces. The integration establishes Myant's physical presence in Taiwan, enabling better service to the Asian market. The company aims to create a global standard for textile computing that interfaces the human operating system with AI for health and wellness applications.

AITech365
Mar 20th, 2025
Myant Launches Care360: AI-Powered Cardiac Assessments Delivered Directly to Patients and Physicians

Myant, a leader in AI-driven healthcare solutions, has unveiled Myant Care360, an innovative service offering precision cardiac assessments directly to patients and physicians.

PR Newswire
Jan 23rd, 2025
Myant Brings The Future Of Disease Prevention To Arab Health 2025

TORONTO, Jan. 23, 2025 /PRNewswire/ -- At Arab Health 2025, Myant will showcase its mission to enable human-centric, precise, and preventive care through continuous connection, a vision brought to life by groundbreaking innovations in AI and Textile Computing™. Backed by cutting-edge R&D and significant investment, Myant is redefining healthcare as proactive, continuous, and deeply personal.As the largest healthcare event in the Middle East, Arab Health provides an unparalleled platform for Myant to connect with global healthcare leaders, unveil transformative solutions, and shape the future of medical innovation. Myant's participation underscores its commitment to empowering people to live healthier, longer lives through revolutionary technology and actionable health insights.Showcasing the Future of Disease PreventionMyant will present Myant Care, a comprehensive platform which combines health data to predict and prevent disease, keeping populations healthy by providing early warnings and interventions. Myant Care uses clinical-grade interfaces for real medical decisions, leveraging deep machine learning to transform continuous health data and scientific literature into actionable care plans.Central to the platform is Skiin Generation 2, the world's first passive, human centric, comfortable, continuous medical-grade remote monitor. It integrates ECG, cuffless blood pressure, breathing pattern and volume, core body temperature, oxygen saturation (SpO2), actigraphy and posture, sleep metrics including sleep apnea diagnosis, offering unparalleled insights into managing hypertension, life-threatening arrhythmias, heart failure, sleep apnea, COPD and other conditions.Skiin Generation 2 unlocks powerful new tools for physicians, including live telemetry during teleconsultations and symptom replay

Il Giornale d'Italia
Jan 16th, 2025
Myant Accelerates Precision Healthcare with Acquisition of Bitnobi Inc.

TORONTO, Jan. 16, 2025 /PRNewswire/ - Myant, a global leader in advanced materials and connected health solutions, proudly announces the acquisition of Toronto-based technology innovator, Bitnobi Inc.

Newswire
Jan 16th, 2025
Myant Acquires Bitnobi for Precision Healthcare

Myant, a leader in connected health solutions, has acquired Bitnobi Inc., a Toronto-based tech firm specializing in privacy-protected data-sharing software. This acquisition enhances Myant's ability to securely share and utilize healthcare data, advancing its mission of precision healthcare. Bitnobi's platform will aid in creating a "digital human replica," supporting proactive and personalized care. This is Myant's fourth strategic acquisition in six months, strengthening its innovation capabilities.